rgx-202
rgenix
['rectal', 'rgx-202 ', 'colorectal', 'inspirna']
today at #asco22, we re sharing data from the ongoing phase 1b clinical trial of rgx-202 for the treatment of colorectal #cancer. for more information: 
Inspirna, Inc. is a clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.